• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶 2 组织抑制剂与代谢综合征中非酒精性脂肪性肝病的相关性。

Association of tissue inhibitor of metalloproteinase 2 with non-alcoholic fatty liver disease in metabolic syndrome.

机构信息

Department of Physiology, Basic Medical Sciences Institute, Jinnah Post graduate Medical Centre , Karachi , Pakistan.

Department of Family, Medicine Aga Khan University , Karachi , Pakistan.

出版信息

Arch Physiol Biochem. 2019 Dec;125(5):441-446. doi: 10.1080/13813455.2018.1481095. Epub 2018 Jun 18.

DOI:10.1080/13813455.2018.1481095
PMID:29912573
Abstract

The aim of this case-control study was to assess TIMP2 level in subjects with or without metabolic syndrome (MetS) and to associate levels with non-alcoholic fatty liver changes (NAFLD). Thirty-three MetS subjects and 55 controls were recruited. Anthropometric data, lipid and glucose profile, TIMP2 and liver ultrasound was performed. High TIMP2 was seen in MetS group (145.28 ± 23.11 pg/ml) versus controls (19.06 ± 1.19 pg/ml;  < .001). Serum cholesterol, triglyceride, LDL-c and glucose levels were significantly higher in MetS subjects ( < .05). MetS individuals (72.72%) showed positive fatty liver changes versus 14.5% controls. Elevated TIMP2 positively correlated with waist circumference, body fat, blood glucose and NAFLD. Furthermore, every unit rise in waist circumference and TIMP2 and a unit decrease in HDL were associated with higher odds of developing NAFLD ( < .05). There may be concurrent relationship between TIMP2 and NAFLD in MetS that requires further evaluation to improve risk assessment and early diagnosis of MetS.

摘要

本病例对照研究旨在评估代谢综合征(MetS)患者和无代谢综合征患者的 TIMP2 水平,并将其与非酒精性脂肪肝变化(NAFLD)相关联。共招募了 33 名 MetS 患者和 55 名对照者。进行了人体测量学数据、血脂和血糖谱、TIMP2 和肝脏超声检查。MetS 组的 TIMP2 水平较高(145.28±23.11pg/ml),而对照组为 19.06±1.19pg/ml( < .001)。MetS 患者的血清胆固醇、甘油三酯、LDL-c 和血糖水平显著升高( < .05)。MetS 患者(72.72%)的脂肪肝变化呈阳性,而对照组为 14.5%。升高的 TIMP2 与腰围、体脂、血糖和 NAFLD 呈正相关。此外,腰围和 TIMP2 每增加一个单位,HDL 减少一个单位,与发生 NAFLD 的几率增加相关( < .05)。TIMP2 和 MetS 中的 NAFLD 之间可能存在并发关系,需要进一步评估以改善 MetS 的风险评估和早期诊断。

相似文献

1
Association of tissue inhibitor of metalloproteinase 2 with non-alcoholic fatty liver disease in metabolic syndrome.基质金属蛋白酶 2 组织抑制剂与代谢综合征中非酒精性脂肪性肝病的相关性。
Arch Physiol Biochem. 2019 Dec;125(5):441-446. doi: 10.1080/13813455.2018.1481095. Epub 2018 Jun 18.
2
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
3
Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.根据国际糖尿病联盟(IDF)代谢综合征标准,对患有或未患有非酒精性脂肪性肝病(NAFLD)的儿科超重人群的血脂谱模式:一项初步研究。
Rom J Intern Med. 2018 Mar 1;56(1):47-54. doi: 10.1515/rjim-2017-0040.
4
Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.尼泊尔一家三级护理医院的非酒精性脂肪性肝病患者的代谢综合征及生化变化
BMC Gastroenterol. 2018 Jul 6;18(1):109. doi: 10.1186/s12876-018-0843-6.
5
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.美国人群中非酒精性脂肪性肝病与代谢异常之间的关联。
J Clin Gastroenterol. 2017 Feb;51(2):160-166. doi: 10.1097/MCG.0000000000000666.
6
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
7
Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.在一家三级护理医院就诊的患有或不患有非酒精性脂肪性肝病的代谢综合征患者的临床情况和肝脏酶水平
Mymensingh Med J. 2023 Apr;32(2):338-347.
8
Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.心外膜脂肪体积和非酒精性脂肪性肝病与代谢综合征的关联:来自CAESAR研究
J Clin Lipidol. 2016 Nov-Dec;10(6):1423-1430.e1. doi: 10.1016/j.jacl.2016.09.007. Epub 2016 Sep 17.
9
Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.肥胖程度、代谢综合征和胰岛素抵抗对肥胖儿童非酒精性脂肪性肝病诊断风险的预测价值。
Can J Gastroenterol Hepatol. 2018 Apr 26;2018:9465784. doi: 10.1155/2018/9465784. eCollection 2018.
10
Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.胆固醇外排能力在脂肪性肝指数升高的受试者中受损,脂肪性肝指数是一种非酒精性脂肪肝的替代指标。
Atherosclerosis. 2018 Oct;277:21-27. doi: 10.1016/j.atherosclerosis.2018.07.028. Epub 2018 Jul 27.

引用本文的文献

1
Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.肥胖中的脂质储存、脂解和脂毒性。
Adv Exp Med Biol. 2024;1460:97-129. doi: 10.1007/978-3-031-63657-8_4.
2
Differential Expression of MMP2 and TIMP2 in Peripheral Blood Mononuclear Cells After Roux-en-Y Gastric Bypass.Roux-en-Y胃旁路术后外周血单个核细胞中MMP2和TIMP2的差异表达
Front Nutr. 2021 Oct 13;8:628759. doi: 10.3389/fnut.2021.628759. eCollection 2021.
3
MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity.
基质金属蛋白酶和组织金属蛋白酶抑制剂水平与肥胖患者的人体测量参数、血压和内皮功能相关。
Sci Rep. 2021 Oct 8;11(1):20052. doi: 10.1038/s41598-021-99577-2.
4
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases.肥胖症和代谢性疾病中脂肪组织的细胞外基质重塑。
Int J Mol Sci. 2019 Oct 2;20(19):4888. doi: 10.3390/ijms20194888.